Sionna Therapeutics

Last updated: March 06, 2024

CEO Mike Cloonan
CEO Mike Cloonan
Country: USA | Funding: $292M (+)

Website: https://www.sionnatx.com/

Sionna’s batch of small molecules will be the first to fully restore function to the cystic fibrosis transmembrane conductance regulator (CFTR) protein